about
Laboratory diagnostics of botulismGlycosylated SV2 and Gangliosides as Dual Receptors for Botulinum Neurotoxin Serotype FUnique Ganglioside Recognition Strategies for Clostridial NeurotoxinsBiodiversity of Clostridium botulinum type E strains isolated from fish and fishery productsGenomic analysis of Clostridium botulinum group II by pulsed-field gel electrophoresis.Diversity of proteolytic Clostridium botulinum strains, determined by a pulsed-field gel electrophoresis approachVaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B.Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade.Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralizationBotulinum toxin: bioweapon & magic drugImmunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge.Molecular gene profiling of Clostridium botulinum group III and its detection in naturally contaminated samples originating from various European countries.Genetic diversity among Botulinum Neurotoxin-producing clostridial strainsIdentification of type A, B, E, and F botulinum neurotoxin genes and of botulinum neurotoxigenic clostridia by denaturing high-performance liquid chromatography.Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal routeNeurotoxin gene profiling of clostridium botulinum types C and D native to different countries within Europe.Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells.Molecular characterization of Clostridium botulinum isolates from foodborne outbreaks in Thailand, 2010.Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes in Clostridium botulinum type A, Ab, and A(B) strainsBotulinum neurotoxin for pain management: insights from animal models.Role of neurotoxin associated proteins in the low pH induced structural changes in the botulinum neurotoxin complex.Lipid diversity among botulinum neurotoxin-producing clostridiaNeurotoxicity of clostridium toxinsToxicity of botulinum toxin type A (BoNT/A)Toxicity of botulinum toxin type B (BoNT/B)Toxicity of botulinum toxin type E (BoNT/E)Toxicity of botulinum toxin type C (BoNT/C)Toxicity of botulinum toxin type D (BoNT/D)Toxicity of botulinum toxin type F (BoNT/F)Toxicity of botulinum toxin type G (BoNT/G)Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.Regulation of Botulinum Neurotoxin Synthesis and Toxin Complex Formation by Arginine and Glucose in Clostridium botulinum ATCC 3502.spores in Polish honey samples
P2860
Q24545819-E3C2AFDD-5332-410F-9F2E-32CC740A60A7Q27655649-72EF15CC-58A8-4872-82D2-6CF4CFF600CCQ27671814-69B4D71F-95A2-40BB-8190-B69B17FB52D5Q30678082-8CFB6AF7-4D9F-4A01-BB7B-B5F8F3AFD75DQ33706421-FF9B5885-0EAE-450A-9391-A5663464FA7EQ33716433-A04F4448-C32A-428C-8270-4FA4403E1D67Q33909140-7D1B6B19-9DE8-4E9A-98CA-0646D4A90A24Q34001804-5DEE9558-97FC-45FD-8839-1D78C656A1F2Q34034156-8372E5EF-AAEB-4E86-8FC8-A081DB2B7BDCQ34530009-99ED11D8-A085-4778-AB50-DBA91008D0E7Q35043107-5B50D552-1028-49C0-9D9B-8696AAC1A1FAQ35172205-098FB71D-740B-498B-8D4B-A01727491C92Q35634548-4479F0C4-35A7-4183-9F52-DF272652534EQ35661634-533F960E-99FD-4CF5-9726-7C14E6DCE63CQ35913397-2A77582D-8B99-47D7-AA9D-3DA2BD4F2BC2Q35941093-9BA8F2B7-862F-4EBC-8E4B-85BFCBCCD4C9Q36325534-B41C58E4-034A-44FB-9E25-239886B041C2Q37521567-26559115-FDF8-4450-9C36-C5ED9DC9DACAQ37701751-63BCCD8D-687A-4232-89B5-04CFB67DBC0BQ37954278-7ECDA7C8-83B3-4801-8F7D-FDB36482BBB0Q41809173-A0ADFB92-DB39-4BCB-8D33-B952982C9C13Q42722351-E2D80C02-7D93-4C8A-B193-1484737D602DQ45316686-7081A47F-9B32-4800-B89D-AEAC0970732DQ45316687-36B31635-8ECF-4C2C-92D7-AFACC0DFA716Q45316688-E21D10A2-88D6-4222-A84B-2862C8A462F9Q45316690-146A81D0-D425-4DA8-813F-0A1B92A00651Q45316693-F5E3A428-29B8-42B1-A428-032BB343FA81Q45316694-69DEB438-2F81-4CF2-B6A8-FB01E26AEAEDQ45316695-561F2785-6A13-42CE-8812-3EC7C05D4A17Q45316696-405F44DA-2599-46D3-8E02-305675748CABQ47373283-E243637E-BA02-4189-8592-A33444133859Q49216299-F5B04AC9-D201-4E78-BFD7-71950AE08291Q59128160-AF75D29B-D77B-435E-8F67-B5CC65EDA631
P2860
description
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1995
@ast
im Januar 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1995/01/01)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/01/01)
@nl
наукова стаття, опублікована в січні 1995
@uk
مقالة علمية (نشرت عام 1995)
@ar
name
Botulism: the present status of the disease
@ast
Botulism: the present status of the disease
@en
Botulism: the present status of the disease
@nl
type
label
Botulism: the present status of the disease
@ast
Botulism: the present status of the disease
@en
Botulism: the present status of the disease
@nl
prefLabel
Botulism: the present status of the disease
@ast
Botulism: the present status of the disease
@en
Botulism: the present status of the disease
@nl
P1476
Botulism: the present status of the disease
@en
P2093
C L Hatheway
P356
10.1007/978-3-642-85173-5_3
P577
1995-01-01T00:00:00Z